These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37419784)

  • 1. Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived.
    Tsimikas S; Bhatia HS; Erlinge D
    J Clin Lipidol; 2023; 17(5):567-570. PubMed ID: 37419784
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population.
    Park SH; Rha SW; Choi BG; Park JY; Jeon U; Seo HS; Kim EJ; Na JO; Choi CU; Kim JW; Lim HE; Park CG; Oh DJ
    Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):588-95. PubMed ID: 25865336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type.
    Gaglia MA; Torguson R; Lipinski MJ; Gai J; Koifman E; Kiramijyan S; Negi S; Rogers T; Steinvil A; Suddath WO; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2016 Feb; 117(4):526-531. PubMed ID: 26739394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
    Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease.
    Wester M; Koll F; Luedde M; Langer C; Resch M; Luchner A; Müller K; Zeman F; Koller M; Maier LS; Sossalla S
    Clin Res Cardiol; 2023 Sep; 112(9):1194-1203. PubMed ID: 36100700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent.
    Seo SM; Kim TH; Koh YS; Her SH; Shin DI; Park HJ; Kim PJ; Park CS; Lee JM; Kim DB; Kim HY; Chang K; Yoo KD; Jeon DS; Chung WS; Seung KB;
    Coron Artery Dis; 2016 Mar; 27(2):143-50. PubMed ID: 26693807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis.
    Zhang H; Zhang Y; Tian T; Wang T; Chen J; Yuan J; Qian J; Hu F; Dou K; Qiao S; Wu Y; Guan C; Xu B; Yang W; Song L
    J Clin Lipidol; 2023; 17(4):458-465. PubMed ID: 37248114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?
    Cui K; Yin D; Zhu C; Song W; Wang H; Jia L; Zhang R; Wang H; Cai Z; Feng L; Dou K
    J Am Heart Assoc; 2022 May; 11(9):e023578. PubMed ID: 35475627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
    Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
    Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
    Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
    Abdallah MS; Wang K; Magnuson EA; Spertus JA; Farkouh ME; Fuster V; Cohen DJ;
    JAMA; 2013 Oct; 310(15):1581-90. PubMed ID: 24129463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Fractional Flow Reserve-Guided Percutaneous Cornary Intervention for Patients with Angina Pectoris.
    Shinohara H; Kodera S; Kiyosue A; Ando J; Morita H; Komuro I
    Int Heart J; 2020 Nov; 61(6):1097-1106. PubMed ID: 33191337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
    Zhang Z; Weintraub WS; Mahoney EM; Spertus JA; Booth J; Nugara F; Stables RH; Vaccarino V
    Am J Cardiol; 2004 Feb; 93(4):404-9. PubMed ID: 14969611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1670-1680. PubMed ID: 35525680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.
    Völz S; Dworeck C; Redfors B; Pétursson P; Angerås O; Gan LM; Götberg M; Sarno G; Venetsanos D; Grimfärd P; Hofmann R; Jensen J; Björklund F; Danielewicz M; Linder R; Råmunddal T; Fröbert O; Witt N; James S; Erlinge D; Omerovic E
    J Am Coll Cardiol; 2020 Jun; 75(22):2785-2799. PubMed ID: 32498806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benefit of elective percutaneous coronary intervention for stable coronary artery disease].
    Ennezat PV; Malergue MC; Czitrom D; Maréchaux S; Tricot O; Le Jemtel TH; Vincentelli A
    Presse Med; 2019 Oct; 48(10):1037-1042. PubMed ID: 31676217
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR.
    Saluveer O; Redfors B; Angerås O; Dworeck C; Haraldsson I; Ljungman C; Petursson P; Odenstedt J; Ioanes D; Lundgren P; Völz S; Råmunddal T; Andersson B; Omerovic E; Bergh N
    Blood Press; 2017 Jun; 26(3):166-173. PubMed ID: 28092977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.